SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon recalls 3,665 bottles of Posaconazole Delayed-Release Tablets in US market

20 Feb 2023 Evaluate

Biocon is recalling 3,665 bottles of Posaconazole Delayed-Release Tablets (100 mg, 60-count bottle) in the US market, used to treat serious fungal infections like invasive aspergillosis. USFDA noted that the New Jersey-based Biocon Pharma Inc is recalling the affected lot due to Failed Impurities/Degradation Specifications: High Out Of Specification degradation results. The lot has been manufactured by Biocon Pharma and distributed in the US by Iselin-based Biocon Pharma Inc.

Biocon initiated the Class II nationwide (US) recall on January 31, this year. As per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×